SL
Siren LLC Portfolio holdings
AUM
$1.93B
1-Year Est. Return
118.08%
1 Year Est. Return
+118.08%
AUM
$1.77B
AUM Growth
-$491M
(-22%)
Holding
140
Top Buys
| 1 | +$64.3M | |
| 2 | +$53.2M | |
| 3 | +$26.8M | |
| 4 |
Edgewise Therapeutics
EWTX
|
+$21.2M |
| 5 |
Rhythm Pharmaceuticals
RYTM
|
+$14.7M |
Top Sells
| 1 | +$70.8M | |
| 2 | +$49.8M | |
| 3 | +$42.2M | |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
+$38.9M |
| 5 |
Cytokinetics
CYTK
|
+$18.9M |
Sector Composition
| 1 | Healthcare | 89.75% |
| 2 | Technology | 5.2% |
| 3 | Communication Services | 2.41% |
| 4 | Consumer Discretionary | 1.21% |
| 5 | Real Estate | 0.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Janux Therapeutics
JANX
$1.79B
| – | – |
-175,000
|
|
||
127
Kura Oncology
KURA
$912M
| – | – |
-1,339,942
|
|
||
|
128
Madrigal Pharmaceuticals
MDGL
$9.57B
| – | – |
-125,942
|
|
||
129
Applied Therapeutics
APLT
$187M
| – | – |
-1,633,768
|
|
||
130
Meta Platforms (Facebook)
META
$1.89T
| – | – |
-1,000
|
|
||
131
monday.com
MNDY
$10.3B
| – | – |
-2,000
|
|
||
132
Nu Holdings
NU
$77B
| – | – |
-50,000
|
|
||
133
Ovid Therapeutics
OVID
$106M
| – | – |
-2,850,000
|
|
||
134
Phathom Pharmaceuticals
PHAT
$961M
| – | – |
-460,753
|
|
||
135
Regenxbio
RGNX
$665M
| – | – |
-284,000
|
|
||
136
Sea Limited
SE
$94.6B
| – | – |
-25,000
|
|
||
|
SLRN
137
DELISTED
ACELYRIN
SLRN
| – | – |
-1,729,665
|
|
||
|
SWTX
138
DELISTED
SpringWorks Therapeutics
SWTX
| – | – |
-1,377,701
|
|
||
|
ACHL
139
DELISTED
Achilles Therapeutics
ACHL
| – | – |
-755,375
|
|
||
|
OMGA
140
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| – | – |
-1,323,530
|
|